In step 7, the absolute survival estimates were used to generate 10-year cancer prevalence estimates. Total prevalence was subdivided into general cancer sequelae like (1) diagnosis and treatment, (2) metastatic phase, and (3) terminal phase for the estimated deaths. After these 3 sequelae were...
Purpose To evaluate the positive predictive value (PPV) of an endometrial cancer case finding algorithm using International Classification of Disease 10th revision Clinical Modification (ICD‐10‐CM) diagnosis codes from US insurance claims for implementation in a planned post‐marketing safety study. ...
These 10-year prevalence estimates were then partitioned into 4 sequelae according to the expected person-time spent in these 4 phases of cancer survival: (1) diagnosis/treatment, (2) remission, (3) metastatic/disseminated, and (4) terminal (eTable 11 in the Supplement). Each sequela ...
(0.1%) participants who withdrew their consent to participate after baseline, 175 (0.07%) from a pilot study, 5 (0.002%) aged <45 years at baseline, 36,216 (13.6%) with a previous cancer diagnosis, 4273 (1.6%) with missing information on overall alcohol consumption and 54 (0.02%) with...
(as the diagnosis of these conditions and procedures can lead to changes in BMI). These variables were arbitrarily chosen based on clinical knowledge and due to the quality of the variables’ registry in the SIDIAP database. Level 2 variables (ie, that vary between individuals) were sex, ...
A first-degree relative (sibling, parent, child) who has had colorectal cancer or adenomatous polyps (screening is considered medically necessary beginning at age 40 years, or 10 years younger than the earliest diagnosis in their family, whichever comes first); or Family history of familial adenom...
In Pathways, we built additional nested ROR-P PRS models adjusted for the following combinations of covariates: age at diagnosis and body mass index (Model 2); age at diagnosis, body mass index, and stage at diagnosis (Model 3); age at diagnosis, body mass index, stage at diagnosis, and...
This date was close to the date of diagnosis of the cases since cases were interviewed on average within three months of diagnosis. The family history of cancer was evaluated separately for mothers, fathers, brothers and sisters, and then among all first-degree relatives taken together. We ...
Participants were followed from the date of the baseline questionnaire until date of ovarian cancer diagnosis, date of death, date the participant moved out of the study area (if applicable), or end of follow-up, whichever came first. Invasive epithelial ovarian cancer, defined by ICD-9 code...
The COVID-19 diagnosis dates ranged from January 1 to December 31, 2020, and the last follow-up date was January 28, 2021. Patients with COVID-19 who had known age (≥18 years) and sex were included. We identified patients with cancer by using ICD-9 and ICD-10 codes. Patients ...